Search Results

Displaying Results 4776-4800 of 13504 "'TEL'"

Jun 17, 2026, 09:07 ET NMRA SHAREHOLDER INVESTIGATION: SueWallSt Investigates Neumora Therapeutics for Possible Securities Law Violations

27th Floor\New York, NY 10004\[email protected]\Tel: (888) SueWallSt\Fax: (212) 363-7171

More news about: SueWallSt.com


Jun 17, 2026, 09:04 ET Minnesota Epilepsy Group Data Breach Alert Issued By Wolf Haldenstein

[email protected] or [email protected]Tel: (800) 575-0735 or (212) 545-4774This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and

More news about: Wolf Haldenstein Adler Freeman & Herz LLP


Jun 17, 2026, 09:00 ET AIR ONE Named Robb Report's 2026 Best Personal Aircraft

Recognition reflects growing momentum behind the smart aircraft categoryTEL AVIV, Israel, June 17, 2026 /PRNewswire/ --

More news about: AIR


Jun 17, 2026, 08:30 ET The 5 Pillars of AI Governance to Reduce GxP Risk, Upcoming Webinar Hosted by Xtalks

https://xtalks.com/partner-with-us/Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Jun 17, 2026, 08:30 ET Effectively Streamlining EU & UK Clinical Trial Sample Testing, Upcoming Webinar Hosted by Xtalks

https://xtalks.com/partner-with-us/Contact: Vera Kovacevic Tel: +1 (416) 977-6555 x371 Email: [email protected]

More news about: Xtalks


Jun 17, 2026, 08:07 ET Next Gen Challenge World Leaders in Youth Manifesto Following Davos 2026

Forum without its endorsement. Press Contact Institut auf dem Rosenberg Höhenweg 60, 9000 St. Gallen, Switzerland Tel.: +41 71 277 77 77 Email: [email protected] Website:

More news about: Institut auf dem Rosenberg


Jun 17, 2026, 07:30 ET America's First VC-Backed Cyber Warfare Startup Raises $100M Series B at $1B Valuation

Co-founder and CEO of Expanse (acquired by Palo Alto Networks for $1.25B in 2020), with early backing from investors including General Catalyst and In-Q-Tel.About TwentyTwenty is America's first VC-backed cyber warfare startup. Founded in 2024, Twenty is industrializing offensive cyber

More news about: Twenty


Jun 17, 2026, 07:10 ET DER DAN DAVID PRIZE, DER WELTWEIT GRÖSSTE GESCHICHTSPREIS, GIBT DIE PREISTRÄGER FÜR 2026 BEKANNT

Straßennetzen in Peru, von der Musik in mittelalterlichen Kathedralen bis hin zu den Ursprüngen moderner FreizeitparksTEL AVIV, Israel, 17. Juni 2026 /PRNewswire/ -- Der Dan David Prize, der weltweit größte Geschichtspreis, gab

More news about: Dan David Prize


Jun 17, 2026, 07:07 ET Four Seasons Education Files Annual Report on Form 20-F for Fiscal Year 2026

contact: In China:Four Seasons Education (Cayman) Inc.Olivia LiTel: +86-21-6317 6177 E-mail: [email protected] Piacente Group, Inc. Jenny CaiTel: +86-10-6508-0677 E-mail: 

More news about: Four Seasons Education Inc.


Jun 17, 2026, 07:00 ET Matricelf Advances Toward First in Human Trial Following Successful GLP Safety Study Completion

TEL AVIV, Israel, June 17, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered tissue implants for spinal cord injury, today announced the successful completion

More news about: Matricelf Ltd.


Jun 17, 2026, 05:00 ET FinVolution Group Publishes Eighth Annual ESG Report

GroupHead of Capital MarketsYam ChengTel: +86 (21) 8030-3200 Ext. 8601E-mail: [email protected] Piacente Financial CommunicationsJenny CaiTel: +86 (10) 6508-0677E-mail:

More news about: FinVolution Group


Jun 17, 2026, 03:48 ET Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat

endometriosis.*NOVA: the Non-hormonal Option – a Vipoglanstat Assessment trialFor more information, please contact:Patric Stenberg, CEOTel: + 46 (0)733 83 66 70E-mail: [email protected]

More news about: Gesynta Pharma


Jun 17, 2026, 03:44 ET Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat

endometriosis.*NOVA: the Non-hormonal Option – a Vipoglanstat Assessment trialFor more information, please contact:Patric Stenberg, CEOTel: + 46 (0)733 83 66 70E-mail: [email protected]

More news about: Gesynta Pharma


Jun 17, 2026, 02:00 ET Lettre aux actionnaires de Workspace Group plc

annonce n'a pas pour objet de constituer et ne constitue ni ne contient aucune recommandation d'investissement au sens du règlement (UE) n° 596/2014 (tel qu'il fait partie intégrante du droit national du Royaume-Uni en vertu de la loi de 2018 sur le retrait de l'Union européenne). Aucune information contenue

More news about: Saba Capital


Jun 17, 2026, 01:39 ET Skanska selected for New Jersey Surface Alignment Project in New Jersey, USA for USD 454M, about SEK 4.3 billion

information please contact:Maritza Ferreira, VP, Communications, Skanska USA, tel +1 (678) 492 2003Olof Rundgren, Media Relations Manager, Skanska, tel +46 10 448 67 94Direct line for media, tel +46 (0)10 448 88 99This and previous releases can also be found at

More news about: Skanska


Jun 16, 2026, 18:14 ET ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Kim, Esq.     The Rosen Law Firm, P.A.     275 Madison Avenue, 40th Floor     New York, NY 10016     Tel: (212) 686-1060     Toll Free: (866) 767-3653     Fax: (212) 202-3827     

More news about: THE ROSEN LAW FIRM, P. A.


Jun 16, 2026, 16:44 ET Elicio Therapeutics Investigation Initiated: SueWallSt Investigates the Officers and Directors of Elicio Therapeutics (ELTX)

Street, 27th FloorNew York, NY [email protected]Tel: (888) SueWallStFax: (212) 363-7171

More news about: SueWallSt.com


Jun 16, 2026, 16:35 ET Ardmore Shipping Exercises Newbuilding Options

Suite 1314New York, NY 10004Tel: 212-477-8438Fax: 212-477-8636Email: [email protected]. Bryan DegnanIGB GroupTel: 646-673-9701Email:

More news about: Ardmore Shipping Corporation


Jun 16, 2026, 14:38 ET SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit

Information:Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Jun 16, 2026, 14:29 ET Graphic Packaging Deadline: GPK Investors with Losses in Excess of $100K Have Opportunity to Lead Graphic Packaging Holding Company Securities Fraud Lawsuit

Information:Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Jun 16, 2026, 14:21 ET ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

Information:Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Jun 16, 2026, 14:14 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Open Lending Corporation (NASDAQ: LPRO)

10118United States of [email protected]Tel: (212) 971-1341Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde &

More news about: Monteverde & Associates PC


Jun 16, 2026, 13:51 ET Manhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. - MANH

Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.